Specifically, ESM1 upregulates the expression of VEGF-A, HIF1α and MMP9 by binding to c-Met and activating the MAPK/ERK pathway (Fig. 4c) [183], which play key roles in tumor angiogenesis, invasion and metastasis. This evidence concerns the gene MET and neoplasm.